Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estimize opens earnings estimates, offers an alternative to sell-side research

Monday, February 18, 2013

amb
Leigh Drogen
Bailey McCann, Opalesque New York:

New York-based startup Estimize is offering free and open earnings estimates by analysts who could be name brand hedge fund managers, or an intrepid follower of the markets. The company, started by Leigh Drogen, a former hedge fund manager himself, seeks to offer up another take on the possible performance of equities, that is less tied to the sell-side incentives driving most earnings data. So far, over 2,300 contributors are providing earnings estimates, creating an earnings consensus that is more accurate than sell-side analysts 67% of the time.

Drogen is staking out new territory in the financial technology space, building on the first principles of Silicon Valley, instead of Goldman Sachs. As a platform, Estimize is a disrupter - one doesn't have to be an analyst trained at one of the farm team programs available at the big firms to provide data. Instead, the community relies on honor in accuracy over bonus incentives. It's also free to sign up and use - a far cry from terminal and research fees common to the industry. On the back end, hedge funds like Two Sigma use Estimize's API to understand the data on the platform and use it for their own models.

"We are producing a dataset that is more accurate to the real expectations of the market," explains Drogen in an interview with Opalesque. Users can sign up anonymously if they wish, Drogen says he prov......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und